ciglitazone has been researched along with Cancer of Colon in 9 studies
ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We found that 15d-PGJ(2) sensitizes colon cancer cells to TWEAK-induced apoptosis." | 1.36 | PPARgamma ligand 15-deoxy-delta 12,14-prostaglandin J2 sensitizes human colon carcinoma cells to TWEAK-induced apoptosis. ( Dionne, S; Levesque, D; Levy, E; Seidman, EG, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pierzchalski, P | 1 |
| Krawiec, A | 1 |
| Gawełko, J | 1 |
| Pawlik, WW | 2 |
| Konturek, SJ | 1 |
| Gonciarz, M | 1 |
| Dionne, S | 1 |
| Levy, E | 1 |
| Levesque, D | 1 |
| Seidman, EG | 1 |
| Papi, A | 1 |
| Rocchi, P | 1 |
| Ferreri, AM | 1 |
| Orlandi, M | 1 |
| Chen, GG | 1 |
| Lee, JF | 1 |
| Wang, SH | 1 |
| Chan, UP | 1 |
| Ip, PC | 1 |
| Lau, WY | 1 |
| Burgermeister, E | 1 |
| Tencer, L | 1 |
| Liscovitch, M | 1 |
| Allred, CD | 1 |
| Kilgore, MW | 1 |
| Kim, E | 1 |
| Chen, F | 1 |
| Wang, CC | 1 |
| Harrison, LE | 1 |
| Yamazaki, K | 1 |
| Shimizu, M | 1 |
| Okuno, M | 1 |
| Matsushima-Nishiwaki, R | 1 |
| Kanemura, N | 1 |
| Araki, H | 1 |
| Tsurumi, H | 1 |
| Kojima, S | 1 |
| Weinstein, IB | 1 |
| Moriwaki, H | 1 |
| Ptak-Belowska, A | 1 |
| Pawlik, MW | 1 |
| Krzysiek-Maczka, G | 1 |
| Brzozowski, T | 1 |
9 other studies available for ciglitazone and Cancer of Colon
| Article | Year |
|---|---|
Molecular mechanism of protection against chemically and gamma-radiation induced apoptosis in human colon cancer cells.
Topics: Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Caco-2 Cells; Colonic Neoplasms; Gamma Ray | 2008 |
PPARgamma ligand 15-deoxy-delta 12,14-prostaglandin J2 sensitizes human colon carcinoma cells to TWEAK-induced apoptosis.
Topics: Apoptosis; Butyrates; Caco-2 Cells; Cell Line, Tumor; Colonic Neoplasms; Cytokine TWEAK; Drug Synerg | 2010 |
RXRgamma and PPARgamma ligands in combination to inhibit proliferation and invasiveness in colon cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Movement; Cell Proliferation; Cell S | 2010 |
Apoptosis induced by activation of peroxisome-proliferator activated receptor-gamma is associated with Bcl-2 and NF-kappaB in human colon cancer.
Topics: Apoptosis; Cell Division; Cell Survival; Colon; Colonic Neoplasms; DNA-Binding Proteins; Electrophor | 2002 |
Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells.
Topics: Adenocarcinoma; Antigens, Differentiation; Antigens, Neoplasm; Breast Neoplasms; Caveolin 1; Caveoli | 2003 |
Selective activation of PPARgamma in breast, colon, and lung cancer cell lines.
Topics: Alitretinoin; Anilides; Breast Neoplasms; Caco-2 Cells; Cell Line, Tumor; Colonic Neoplasms; Female; | 2005 |
CDK5 is a novel regulatory protein in PPARgamma ligand-induced antiproliferation.
Topics: Adaptor Proteins, Signal Transducing; Cell Cycle Proteins; Cell Proliferation; Colonic Neoplasms; Cy | 2006 |
Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells--phosphorylated RXR alpha is a critical target for colon cancer management.
Topics: Caco-2 Cells; Colonic Neoplasms; Drug Synergism; Female; Growth Inhibitors; Humans; Male; Phosphoryl | 2007 |
Transcriptional upregulation of gastrin in response to peroxisome proliferator-activated receptor gamma agonist triggers cell survival pathways.
Topics: Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Gastrins; Humans; | 2007 |